AFT Pharmaceuticals Limited (ASX: AFP)
Sector: Health Care
Market cap: A$380M (as of 2 Nov 2026)
AFT is a growing multinational pharmaceutical business with a broad range of products, both developed itself and in-licensed from third parties. AFT's products cover all major pharmaceutical distribution channels: over-the-counter, prescription and hospital.
Data as of 2 Nov 2026.
Recent capital raises
| Date | Type | Amount | Price | Discount | Source |
|---|---|---|---|---|---|
| 30 June 2020 | SPP | $2M | $3.75 | — | Filing ↗ |
Substantial holders — latest moves
| Date | Holder | Move | Holding | Source |
|---|---|---|---|---|
| 1 Sept 2025 | David Mark Flacks | Increase | — | Filing ↗ |
| 4 July 2025 | Hartley Campbell Atkinson | Increase | — | Filing ↗ |
| 27 June 2025 | Hartley Campbell Atkinson | Increase | — | Filing ↗ |
| 22 May 2025 | Hartley Campbell Atkinson and Colin McKay as trustees of the Atkinson Family Trust | Entry | ?% → 69.51% | Filing ↗ |
| 27 Nov 2024 | Andrew Lane | Increase | — | Filing ↗ |
Director trades — on-market
Latest guidance
| Date | Period | Guidance | Source |
|---|---|---|---|
| 6 Oct 2026 | FY27 | AFT reports double digit growth in 1H FY27 and R&D progress | Filing ↗ |
Ask about AFP in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has AFP raised money in the last year, and at what discount?
- What was AFP's latest cash position and runway?
Loading AFP…